BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31794605)

  • 1. Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender Individuals.
    Wiik A; Lundberg TR; Rullman E; Andersson DP; Holmberg M; Mandić M; Brismar TB; Dahlqvist Leinhard O; Chanpen S; Flanagan JN; Arver S; Gustafsson T
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31794605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.
    Defreyne J; Elaut E; Kreukels B; Fisher AD; Castellini G; Staphorsius A; Den Heijer M; Heylens G; T'Sjoen G
    J Sex Med; 2020 Apr; 17(4):812-825. PubMed ID: 32008926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
    Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
    Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis.
    Karalexi MA; Georgakis MK; Dimitriou NG; Vichos T; Katsimpris A; Petridou ET; Papadopoulos FC
    Psychoneuroendocrinology; 2020 Sep; 119():104721. PubMed ID: 32512250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
    Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Flügel AK; Herrmann E; Bojunga J
    Eur J Endocrinol; 2020 Feb; 182(2):149-156. PubMed ID: 31751300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
    Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
    J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment.
    de Blok CJM; Dijkman BAM; Wiepjes CM; Staphorsius AS; Timmermans FW; Smit JM; Dreijerink KMA; den Heijer M
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e782-e790. PubMed ID: 33206172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Gender-Affirming Hormone Therapy on Insulin Sensitivity and Incretin Responses in Transgender People.
    Shadid S; Abosi-Appeadu K; De Maertelaere AS; Defreyne J; Veldeman L; Holst JJ; Lapauw B; Vilsbøll T; T'Sjoen G
    Diabetes Care; 2020 Feb; 43(2):411-417. PubMed ID: 31740479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.
    Rowniak S; Bolt L; Sharifi C
    JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1826-1854. PubMed ID: 31021971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No correlation between serum testosterone levels and state-level anger intensity in transgender people: Results from the European Network for the Investigation of Gender Incongruence.
    Defreyne J; Kreukels B; T'Sjoen G; Staphorsius A; Den Heijer M; Heylens G; Elaut E
    Horm Behav; 2019 Apr; 110():29-39. PubMed ID: 30822410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrinology of Transgender Medicine.
    T'Sjoen G; Arcelus J; Gooren L; Klink DT; Tangpricha V
    Endocr Rev; 2019 Feb; 40(1):97-117. PubMed ID: 30307546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Gender-Affirming Hormone Therapy on Measures of Kidney Function: A Systematic Review and Meta-Analysis.
    Krupka E; Curtis S; Ferguson T; Whitlock R; Askin N; Millar AC; Dahl M; Fung R; Ahmed SB; Tangri N; Walsh M; Collister D
    Clin J Am Soc Nephrol; 2022 Sep; 17(9):1305-1315. PubMed ID: 35973728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatologic Conditions in Transgender Populations.
    Yeung H; Kahn B; Ly BC; Tangpricha V
    Endocrinol Metab Clin North Am; 2019 Jun; 48(2):429-440. PubMed ID: 31027550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does hormone transition in transgender women change body composition, muscle strength and haemoglobin? Systematic review with a focus on the implications for sport participation.
    Harper J; O'Donnell E; Sorouri Khorashad B; McDermott H; Witcomb GL
    Br J Sports Med; 2021 Aug; 55(15):865-872. PubMed ID: 33648944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular implications of gender-affirming hormone treatment in the transgender population.
    Dutra E; Lee J; Torbati T; Garcia M; Merz CNB; Shufelt C
    Maturitas; 2019 Nov; 129():45-49. PubMed ID: 31547912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive functions and fertility preservation in transgender women: a French case series.
    Sermondade N; Benaloun E; Berthaut I; Moreau E; Prades M; Béranger A; Chabbert-Buffet N; Johnson N; Lévy R; Dupont C
    Reprod Biomed Online; 2021 Aug; 43(2):339-345. PubMed ID: 34144898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals.
    Cheung AS; Lim HY; Cook T; Zwickl S; Ginger A; Chiang C; Zajac JD
    J Clin Endocrinol Metab; 2021 Mar; 106(3):893-901. PubMed ID: 32810277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is size in the eye of the beholder? Visual estimation of penis size among transgender and cisgender people and implications for genital gender-affirming surgery and sexual medicine.
    Castaneda PR; Zaliznyak M; Sandhu SS; Cook-Wiens G; Smith SM; Mallavarapu S; Garcia MM
    J Sex Med; 2024 Jan; 21(2):175-180. PubMed ID: 38112322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.